{"transactions":[{"id":1749083,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-11-06T21:15:24.000Z","date":"2023-11-02","kind":"grant","planned":false,"acquired":true,"shares":74218,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan, as amended: (a) on May 2, 2024, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":74218,"derivative":{"exercise_price":1.28,"expiration_date":"2033-11-02","underlying":"Common Stock, par value $0.01 per share","underlying_shares":74218},"source":{"system":"sec-edgar","filing":"0001493152-23-039531","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315223039531/ownership.xml","form_type":"4"}},{"id":2152286,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-09-23T10:41:25.000Z","date":"2022-09-21","kind":"grant","acquired":true,"shares":16637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 21, 2023, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":16637,"derivative":{"exercise_price":5.71,"expiration_date":"2032-09-21","underlying":"Common Stock, par value $0.01 per share","underlying_shares":16637},"source":{"system":"sec-edgar","filing":"0001493152-22-026614","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315222026614/ownership.xml","form_type":"4"}},{"id":2550213,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-10-05T22:15:15.000Z","date":"2021-09-29","kind":"grant","acquired":true,"shares":13571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2020 Omnibus Performance Award Plan: (a) on March 29, 2022, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":13571,"derivative":{"exercise_price":7,"expiration_date":"2031-09-29","underlying":"Common Stock, par value $0.01 per share","underlying_shares":13571},"source":{"system":"sec-edgar","filing":"0001493152-21-024672","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315221024672/ownership.xml","form_type":"4"}},{"id":2988787,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-11-09T22:15:10.000Z","date":"2020-11-05","kind":"grant","acquired":true,"shares":2771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on May 5, 2021, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":2771,"derivative":{"exercise_price":7.22,"expiration_date":"2030-11-05","underlying":"Common Stock, par value $0.01 per share","underlying_shares":2771},"source":{"system":"sec-edgar","filing":"0001493152-20-020844","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220020844/ownership.xml","form_type":"4"}},{"id":3002449,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-21T21:25:28.000Z","date":"2020-10-12","kind":"sale","acquired":false,"shares":20000,"price":7.8449,"value":156898.0,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"date","element":"transactionDate","label":"F1","text":"The original Form 4 filed on October 13, 2020 is amended by this Form 4 amendment to correctly reflect the transaction date in Table 1, Item 2. No other changes have been made to the original Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 20,000 shares of Issuer common stock on October 12, 2020. Accordingly, Reporting Person beneficially owned 246,909 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":246909,"source":{"system":"sec-edgar","filing":"0001493152-20-019763","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220019763/ownership.xml","form_type":"4/A","original_submission_date":"2020-10-13"}},{"id":3002447,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-21T21:22:42.000Z","date":"2020-10-19","kind":"sale","acquired":false,"shares":4881,"price":7.9358,"value":38734.6398,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 4,881 shares of Issuer common stock on October 19, 2020. Accordingly, Reporting Person beneficially owned 242,028 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":242028,"source":{"system":"sec-edgar","filing":"0001493152-20-019762","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220019762/ownership.xml","form_type":"4"}},{"id":3008759,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-13T21:00:09.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":20000,"price":7.8449,"value":156898.0,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 20,000 shares of Issuer common stock on October 12, 2020. Accordingly, Reporting Person beneficially owned 246,909 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":246909,"source":{"system":"sec-edgar","filing":"0001493152-20-019358","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220019358/ownership.xml","form_type":"4"}},{"id":3012051,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T20:58:17.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":5119,"price":7.7431,"value":39636.9289,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 20,000 shares of Issuer common stock on October 5, 2020. Accordingly, Reporting Person beneficially owned 266,909 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":266909,"source":{"system":"sec-edgar","filing":"0001493152-20-019036","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220019036/ownership.xml","form_type":"4"}},{"id":3012050,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-06T20:58:17.000Z","date":"2020-10-05","kind":"sale","acquired":false,"shares":14881,"price":7.7423,"value":115213.1663,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 20,000 shares of Issuer common stock on October 5, 2020. Accordingly, Reporting Person beneficially owned 266,909 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":272028,"source":{"system":"sec-edgar","filing":"0001493152-20-019036","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220019036/ownership.xml","form_type":"4"}},{"id":3052978,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-19T20:30:27.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":119,"price":11.9113,"value":1417.4447,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 15,119 shares of Issuer common stock on August 17, 2020. Accordingly, Reporting Person beneficially owned 286,909 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":286909,"source":{"system":"sec-edgar","filing":"0001493152-20-016316","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220016316/ownership.xml","form_type":"4"}},{"id":3052977,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-19T20:30:27.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":15000,"price":10.1784,"value":152676.0,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 15,119 shares of Issuer common stock on August 17, 2020. Accordingly, Reporting Person beneficially owned 286,909 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":287028,"source":{"system":"sec-edgar","filing":"0001493152-20-016316","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315220016316/ownership.xml","form_type":"4"}},{"id":3388916,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-10-24T23:21:02.000Z","date":"2019-10-23","kind":"grant","acquired":true,"shares":3952,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on April 23, 2020, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":3952,"derivative":{"exercise_price":5.06,"expiration_date":"2029-10-23","underlying":"Common Stock, par value $0.01 per share","underlying_shares":3952},"source":{"system":"sec-edgar","filing":"0001493152-19-015942","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315219015942/ownership.xml","form_type":"4"}},{"id":3689883,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-23T22:44:48.000Z","date":"2019-01-21","kind":"grant","acquired":true,"shares":2326,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on March 4, 2019, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":2326,"derivative":{"exercise_price":8.6,"expiration_date":"2029-01-21","underlying":"Common Stock, par value $0.01 per share","underlying_shares":2326},"source":{"system":"sec-edgar","filing":"0001493152-19-000864","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315219000864/ownership.xml","form_type":"4"}},{"id":4102394,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-10T21:49:03.000Z","date":"2018-01-09","kind":"sale","acquired":false,"shares":35000,"price":1.0626,"value":37191.0,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 35,000 shares of Issuer common stock on January 9, 2018. Accordingly, Reporting Person beneficially owned 4,530,409 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":4530409,"source":{"system":"sec-edgar","filing":"0001493152-18-000421","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315218000421/form4.xml","form_type":"4"}},{"id":4108955,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T18:55:18.000Z","date":"2018-01-03","kind":"sale","acquired":false,"shares":2868,"price":1.0056,"value":2884.0608,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 2,868 shares of Issuer common stock on January 3, 2018. Accordingly, Reporting Person beneficially owned 4,565,409 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":4565409,"source":{"system":"sec-edgar","filing":"0001493152-18-000142","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315218000142/form4.xml","form_type":"4"}},{"id":4114631,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-01-03T20:12:48.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":42132,"price":1.0091,"value":42515.4012,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 42,132 shares of Issuer common stock on January 2, 2018. Accordingly, Reporting Person beneficially owned 4,568,277 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":4568277,"source":{"system":"sec-edgar","filing":"0001493152-18-000089","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315218000089/form4.xml","form_type":"4"}},{"id":4120583,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-28T18:21:31.000Z","date":"2017-12-27","kind":"sale","acquired":false,"shares":14257,"price":1.0222,"value":14573.5054,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 14,257 shares of Issuer common stock on December 27, 2017. Accordingly, Reporting Person beneficially owned 4,610,409 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":4610409,"source":{"system":"sec-edgar","filing":"0001493152-17-015176","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217015176/form4.xml","form_type":"4"}},{"id":4121310,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-27T21:32:11.000Z","date":"2017-12-26","kind":"sale","acquired":false,"shares":30743,"price":1.0219,"value":31416.2717,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 30,743 shares of Issuer common stock on December 26, 2017. Accordingly, Reporting Person beneficially owned 4,624,666 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":4624666,"source":{"system":"sec-edgar","filing":"0001493152-17-015110","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217015110/form4.xml","form_type":"4"}},{"id":4124360,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-21T22:03:47.000Z","date":"2017-12-20","kind":"sale","acquired":false,"shares":12933,"price":1.0306,"value":13328.7498,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 45,000 shares of Issuer common stock on December 19, 2017 and December 20, 2017. Accordingly, Reporting Person beneficially owned 4,655,409 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":4655409,"source":{"system":"sec-edgar","filing":"0001493152-17-014953","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217014953/form4.xml","form_type":"4"}},{"id":4124359,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-21T22:03:47.000Z","date":"2017-12-19","kind":"sale","acquired":false,"shares":32067,"price":1.03,"value":33029.01,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 45,000 shares of Issuer common stock on December 19, 2017 and December 20, 2017. Accordingly, Reporting Person beneficially owned 4,655,409 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":4655409,"source":{"system":"sec-edgar","filing":"0001493152-17-014953","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217014953/form4.xml","form_type":"4"}},{"id":4132380,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-14T17:55:31.000Z","date":"2017-12-13","kind":"sale","acquired":false,"shares":841,"price":1.02,"value":857.82,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 841 shares of Issuer common stock on December 13, 2017. Accordingly, Reporting Person beneficially owned 4,700,409 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":4700409,"source":{"system":"sec-edgar","filing":"0001493152-17-014589","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217014589/form4.xml","form_type":"4"}},{"id":4134000,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-13T21:44:51.000Z","date":"2017-12-12","kind":"sale","acquired":false,"shares":44159,"price":1.0372,"value":45801.7148,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 44,159 shares of Issuer common stock on December 12, 2017. Accordingly, Reporting Person beneficially owned 4,701,250 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":4701250,"source":{"system":"sec-edgar","filing":"0001493152-17-014564","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217014564/form4.xml","form_type":"4"}},{"id":4138448,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-08T22:05:11.000Z","date":"2017-12-06","kind":"grant","acquired":true,"shares":38095,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest as follows and in accordance with the terms of the Issuer's 2017 Equity Incentive Plan: (a) on the six month anniversary of the date of grant, the option shall vest and shall become exercisable with respect to 25% of the common stock; and (b) on a quarterly basis over the next 30 months, the option shall equally vest and become exercisable with respect to the remaining 75% of the common stock."}],"balance_after":38095,"derivative":{"exercise_price":1.05,"expiration_date":"2027-12-06","underlying":"Common Stock, par value $0.01 per share","underlying_shares":38095},"source":{"system":"sec-edgar","filing":"0001493152-17-014419","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217014419/form4.xml","form_type":"4"}},{"id":4139618,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-07T23:22:42.000Z","date":"2017-12-06","kind":"sale","acquired":false,"shares":15375,"price":1.0509,"value":16157.5875,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 15,375 shares of Issuer common stock on December 6, 2017. Accordingly, Reporting Person beneficially owned 4,745,409 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":4745409,"source":{"system":"sec-edgar","filing":"0001493152-17-014345","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217014345/form4.xml","form_type":"4"}},{"id":4140887,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-12-06T23:29:21.000Z","date":"2017-12-05","kind":"sale","acquired":false,"shares":29625,"price":1.0845,"value":32128.3125,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 29,625 shares of Issuer common stock on December 5, 2017. Accordingly, Reporting Person beneficially owned 4,760,784 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":4760784,"source":{"system":"sec-edgar","filing":"0001493152-17-014280","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217014280/form4.xml","form_type":"4"}},{"id":4149589,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-29T21:57:29.000Z","date":"2017-11-28","kind":"sale","acquired":false,"shares":45000,"price":1.0733,"value":48298.5,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 45,000 shares of Issuer common stock on November 28, 2017. Accordingly, Reporting Person beneficially owned 4,790,409 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":4790409,"source":{"system":"sec-edgar","filing":"0001493152-17-013958","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217013958/form4.xml","form_type":"4"}},{"id":4149588,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-11-29T21:55:32.000Z","date":"2017-11-21","kind":"sale","acquired":false,"shares":45000,"price":1.2104,"value":54468.0,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 45,000 shares of Issuer common stock on November 21, 2017. Accordingly, Reporting Person beneficially owned 4,835,409 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":4835409,"source":{"system":"sec-edgar","filing":"0001493152-17-013956","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217013956/form4.xml","form_type":"4"}},{"id":4180309,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-26T16:54:18.000Z","date":"2017-10-24","kind":"sale","acquired":false,"shares":25000,"price":1.1318,"value":28295.0,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 50,000 shares of Issuer common stock on October 24, 2017. Accordingly, Reporting Person beneficially owned 4,880,399 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":4880399,"source":{"system":"sec-edgar","filing":"0001493152-17-012078","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217012078/form4.xml","form_type":"4"}},{"id":4180308,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-26T16:54:18.000Z","date":"2017-10-24","kind":"sale","acquired":false,"shares":25000,"price":1.1382,"value":28455.0,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 50,000 shares of Issuer common stock on October 24, 2017. Accordingly, Reporting Person beneficially owned 4,880,399 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":4880399,"source":{"system":"sec-edgar","filing":"0001493152-17-012078","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217012078/form4.xml","form_type":"4"}},{"id":4180878,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-25T19:54:55.000Z","date":"2017-10-17","kind":"sale","acquired":false,"shares":25000,"price":1.1567,"value":28917.5,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 50,000 shares of Issuer common stock on October 17, 2017. Accordingly, Reporting Person beneficially owned 4,930,399 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":4930399,"source":{"system":"sec-edgar","filing":"0001493152-17-012045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217012045/form4.xml","form_type":"4"}},{"id":4180877,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-25T19:54:55.000Z","date":"2017-10-17","kind":"sale","acquired":false,"shares":25000,"price":1.1687,"value":29217.5,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 50,000 shares of Issuer common stock on October 17, 2017. Accordingly, Reporting Person beneficially owned 4,930,399 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":4930399,"source":{"system":"sec-edgar","filing":"0001493152-17-012045","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217012045/form4.xml","form_type":"4"}},{"id":4188418,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-11T22:26:30.000Z","date":"2017-10-10","kind":"sale","acquired":false,"shares":25000,"price":1.3891,"value":34727.5,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd. (2"},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 50,000 shares of Issuer common stock on October 10, 2017. Accordingly, Reporting Person beneficially owned 5,020,409 shares of Issuer common stock following the reported transactions."}],"balance_after":5020409,"source":{"system":"sec-edgar","filing":"0001493152-17-011518","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217011518/form4.xml","form_type":"4"}},{"id":4188417,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-11T22:26:30.000Z","date":"2017-10-10","kind":"sale","acquired":false,"shares":25000,"price":1.3671,"value":34177.5,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 50,000 shares of Issuer common stock on October 10, 2017. Accordingly, Reporting Person beneficially owned 5,020,409 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":5020409,"source":{"system":"sec-edgar","filing":"0001493152-17-011518","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217011518/form4.xml","form_type":"4"}},{"id":4189547,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-10T22:17:30.000Z","date":"2017-10-05","kind":"sale","acquired":false,"shares":22000,"price":1.4908,"value":32797.6,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 22,000 shares of Issuer common stock on October 5, 2017. Accordingly, Reporting Person beneficially owned 5,070,409 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":5070409,"source":{"system":"sec-edgar","filing":"0001493152-17-011463","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217011463/form4.xml","form_type":"4"}},{"id":4191417,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-05T18:06:14.000Z","date":"2017-10-04","kind":"sale","acquired":false,"shares":3000,"price":1.48,"value":4440.0,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 53,000 shares of Issuer common stock on October 3, 2017 and October 4, 2017. Accordingly, Reporting Person beneficially owned 5,092,409 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":5092409,"source":{"system":"sec-edgar","filing":"0001493152-17-011297","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217011297/form4.xml","form_type":"4"}},{"id":4191416,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-05T18:06:14.000Z","date":"2017-10-03","kind":"sale","acquired":false,"shares":25000,"price":1.1735,"value":29337.5,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 53,000 shares of Issuer common stock on October 3, 2017 and October 4, 2017. Accordingly, Reporting Person beneficially owned 5,092,409 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":5092409,"source":{"system":"sec-edgar","filing":"0001493152-17-011297","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217011297/form4.xml","form_type":"4"}},{"id":4191415,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-10-05T18:06:14.000Z","date":"2017-10-03","kind":"sale","acquired":false,"shares":25000,"price":1.1883,"value":29707.5,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 53,000 shares of Issuer common stock on October 3, 2017 and October 4, 2017. Accordingly, Reporting Person beneficially owned 5,092,409 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":5092409,"source":{"system":"sec-edgar","filing":"0001493152-17-011297","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217011297/form4.xml","form_type":"4"}},{"id":4200414,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-28T16:53:14.000Z","date":"2017-09-26","kind":"sale","acquired":false,"shares":25000,"price":1.2273,"value":30682.5,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 50,000 shares of Issuer common stock on September 26, 2017. Accordingly, Reporting Person beneficially owned 5,145,409 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":5145409,"source":{"system":"sec-edgar","filing":"0001493152-17-011018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217011018/form4.xml","form_type":"4"}},{"id":4200413,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-28T16:53:14.000Z","date":"2017-09-26","kind":"sale","acquired":false,"shares":25000,"price":1.2487,"value":31217.5,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Reporting Person, through his Rule 10b5-1 trading plan, sold an aggregate of 50,000 shares of Issuer common stock on September 26, 2017. Accordingly, Reporting Person beneficially owned 5,145,409 shares of Issuer common stock following the reported transactions."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":5145409,"source":{"system":"sec-edgar","filing":"0001493152-17-011018","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217011018/form4.xml","form_type":"4"}},{"id":4205130,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-20T15:42:16.000Z","date":"2017-09-19","kind":"sale","acquired":false,"shares":25000,"price":1.1752,"value":29380.0,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":5195409,"source":{"system":"sec-edgar","filing":"0001493152-17-010767","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217010767/form4.xml","form_type":"4"}},{"id":4205129,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-20T15:42:16.000Z","date":"2017-09-19","kind":"sale","acquired":false,"shares":25000,"price":1.1941,"value":29852.5,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":5220409,"source":{"system":"sec-edgar","filing":"0001493152-17-010767","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217010767/form4.xml","form_type":"4"}},{"id":4209767,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-14T19:38:20.000Z","date":"2017-09-12","kind":"sale","acquired":false,"shares":20000,"price":1.12,"value":22400.0,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":5204799,"source":{"system":"sec-edgar","filing":"0001493152-17-010597","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217010597/form4.xml","form_type":"4"}},{"id":4215323,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T23:22:33.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":20000,"price":1.01,"value":20200.0,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":5224799,"source":{"system":"sec-edgar","filing":"0001493152-17-010332","document":"form-4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217010332/form-4.xml","form_type":"4"}},{"id":4215322,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T23:22:33.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":610,"price":1.08,"value":658.8,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":5244799,"source":{"system":"sec-edgar","filing":"0001493152-17-010332","document":"form-4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217010332/form-4.xml","form_type":"4"}},{"id":4215321,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T23:22:33.000Z","date":"2017-09-06","kind":"sale","acquired":false,"shares":25000,"price":1,"value":25000.0,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":5245409,"source":{"system":"sec-edgar","filing":"0001493152-17-010332","document":"form-4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217010332/form-4.xml","form_type":"4"}},{"id":4215320,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T23:20:30.000Z","date":"2017-08-30","kind":"sale","acquired":false,"shares":5000,"price":1.0605,"value":5302.5,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":5270409,"source":{"system":"sec-edgar","filing":"0001493152-17-010331","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217010331/form4.xml","form_type":"4"}},{"id":4215319,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T23:20:30.000Z","date":"2017-08-30","kind":"sale","acquired":false,"shares":5000,"price":1.07,"value":5350.0,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":5275409,"source":{"system":"sec-edgar","filing":"0001493152-17-010331","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217010331/form4.xml","form_type":"4"}},{"id":4215318,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T23:17:13.000Z","date":"2017-08-25","kind":"sale","acquired":false,"shares":15000,"price":1.0808,"value":16212.0,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":5280409,"source":{"system":"sec-edgar","filing":"0001493152-17-010330","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217010330/form4.xml","form_type":"4"}},{"id":4215317,"issuer":{"id":6767,"kind":"organization","name":"Microbot Medical Inc."},"owners":[{"id":58563,"kind":"person","name":"Bornstein Yoseph","position":1,"cik":"0001690100","reported_name":"Bornstein Yoseph","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2017-09-07T23:17:13.000Z","date":"2017-08-24","kind":"sale","acquired":false,"shares":10000,"price":1.0311,"value":10311.0,"ownership":{"direct":false,"nature":"By LSA- LifeScience Accelerator Ltd."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Mr. Bornstein is the CEO and Director of LSA- Life Science Accelerator Ltd. (\"LSA\") and of Shizim Ltd. (\"Shizim\"), and Mr. Bornstein is the majority equity owner of Shizim. Shizim is the majority equity owner of LSA. Accordingly, Mr. Bornstein may be deemed to share voting and investment power over the shares beneficially owned by these entities."}],"balance_after":5295409,"source":{"system":"sec-edgar","filing":"0001493152-17-010330","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/883975/000149315217010330/form4.xml","form_type":"4"}}]}